onesano S.A. (FRA:X2Z)

Germany · Delayed Price · Currency is EUR

0.1255

+0.0085 (7.26%)

Last updated: Aug 27, 2026, 8:16 AM CET

-27.03% (1Y)

Market Cap	8.72M -37.7%
Revenue (ttm)	3.09M +16.1%
Net Income	-1.06M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1255
Previous Close	0.1170
Day's Range	0.1255 - 0.1255
52-Week Range	0.1150 - 0.2100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About onesano

onesano S.A. engages in the production of products related to nutritional cycle, from agricultural production, through animal breeding, to dietetics and human supplementation in Poland. The company offers omega-3, 6, and 9 fatty acids; postbiotic Yarrowia lipolytica Novel Food, solutions in animal nutrition and dietetics; solutions in the field of bioremediation for hydrocarbon-contaminated soil based on the unique postbiotic Yarrowia lipolytica; veterinary products. It also provides dietary supplements and nutraceuticals under the EstroVita an... [Read more]

Industry Pharmaceutical Preparations

Founded 2001

Employees 42

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol X2Z

Financial Performance

In 2025, onesano's revenue was 11.93 million, an increase of 11.58% compared to the previous year's 10.69 million. Losses were -4.79 million, -17.32% less than in 2024.

Financial numbers in PLN Financial Statements